VLPBio

VLPbio is a Spanish biotechnology company developing novel vaccines for animal health, established under its parent company BDi Group. It uses a specialized technology platform based on Chimeric Virus-Like particles (Ch-VLPs) to develop vaccines to target various pathologies in veterinary medicine. The Ch-VLP platform is an antigen-display system, designed to present immunogenic components to the immune system, thereby eliciting specific immune responses without using live pathogens.

The company vaccine pipeline includes solutions to combat serious animal diseases such as infectious bursal disease, porcine reproductive and respiratory syndrome virus, porcine circovirus, and bovine viral diarrhea virus.

Key customers and partnerships

VLPbio has been involved in funded projects by prominent organizations such as the Ministry of Science and Innovation and the European Union's Horizon 2020 research and innovation program.

Funding and financials

In February 2018, the company raised EUR 800,000 (~USD 992,600) in seed funding led by Dyadic International and Inveready Technology Investments.